Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT01004744

Completed

Pre-Surgical Intervention for Targeted Therapies for Breast Cancer

Invasive Breast Cancer
NCT03524261

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer

Advanced Breast Cancer
NCT04148586

Completed

Trial Comparing 3 Schedules of Hypofractionated Whole Breast Irradiation in Females With Early Stage Breast Cancer

Breast Cancer Female
NCT04516330

Completed

Can MicroRNA's Predict Multicentricity in Breast Cancer?

Multicentric Breast Cancer
NCT02473120

Completed

Study of ESR1 Mutations in Metastatic Breast Cancer (FMER)

Metastatic Breast Cancer
NCT04049305

Unknown

Robotic Versus Conventional or Endoscopic Nipple Sparing Mastectomy for Breast Cancer (RCENSM-R)

Breast Cancer Female
NCT02753595

Terminated

Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer
NCT03955939

Completed

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

Metastatic Breast Cancer
NCT04368442

Unknown

Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation (BRCAm)

Breast Cancer Metastatic
NCT03878017

Unknown

A Novel Method of Clipped Axillary Lymph Node Localization Post Neoadjuvant Chemotherapy in Breast Cancer Patients .

Breast Cancer Female
NCT02642406

Unknown

Therapy Management With Nab-Paclitaxel in Daily Routine (SERAPHINA)

Metastatic Breast Cancer
NCT00732433

Completed

Digital Mammography: Computer-Aided Breast Cancer Diagnosis

Tumors, Breast
NCT02611310

Terminated

A Study to Observe Treatment Patterns and Outcomes in Participants in Saudi Arabia With Human Epidermal Growth Factor Receptor 2 (HER2-Positive) Unresectable Locally Advanced or Metastatic Breast Cancer (LA/mBC)

Metastatic Breast Cancer
NCT00574236

Terminated

Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer

Metastatic Breast Cancer
NCT01671319

Completed

Dose Dense TC + Pegfilgrastim Support for Breast Cancer (ddTC)

Female Breast Cancer
NCT03505528

Completed

An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer (Epi-PRIMED)

Metastatic Breast Cancer
NCT03209518

Completed

Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

Premenopausal Breast Cancer
NCT00240071

Completed

Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.

Metastatic Breast Cancer
NCT01856543

Completed

Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation

Invasive Breast Cancer
NCT00274469

Completed

A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer (FIRST)

Metastatic Breast Cancer
NCT03262831

Completed

Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer

Breast Cancer | Cancer of Breast
NCT00759642

Terminated

Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy

Metastatic Breast Cancer
NCT01660529

Completed

Multi-peptide Vaccine With Basilixumab for Breast Cancer

Metastatic Breast Cancer
NCT03507088

Completed

Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer

Metastatic Breast Cancer
NCT03456973

Completed

Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer (NurseAMIE)

Metastatic Breast Cancer
NCT03855423

Unknown

Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer (Matriac)

Breast Cancer Female
NCT02592746

Unknown

A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC

Metastatic Breast Cancer
NCT03876587

Unknown

Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC

Metastatic Breast Cancer
NCT00418028

Completed

Standard Versus Continuous Capecitabine in Advanced Breast Cancer

Metastatic Breast Cancer
NCT02129556

Completed

Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer (PANACEA)

Metastatic Breast Cancer
NCT03830294

Completed

Physical and Psychological Effects of Different Temperature-controlled Breast Prostheses on Patients With Breast Cancer

External Breast Prostheses
NCT03127332

Withdrawn

Metastatic Breast Cancer Treatment Planning

Metastatic Breast Cancer
NCT03240224

Completed

Bioinformation Therapy for Breast Cancer

Advanced Breast Cancer
NCT01663727

Completed

Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer

Metastatic Breast Cancer
NCT02445482

Completed

SOLTI Breast Cancer Molecular Screening Program (AGATA) (AGATA)

Metastatic Breast Cancer
NCT03555227

Completed

USG PECS vs LIA for Breast Cancer Surgery

Breast Cancer Female
NCT03732391

Unknown

Phase 2 Study of Pembrolizumab+Carboplatin in Breast Related Cancer Antigens-related Metastatic Breast Cancer (PEMBRACA)

Metastatic Breast Cancer
NCT00225758

Terminated

Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy

Metastatic Breast Cancer
NCT02361112

Completed

Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer (BLTN-Ic)

Metastatic Breast Cancer
NCT00627978

Completed

Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons

Metastatic Breast Cancer
NCT02738970

Completed

A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)

Early Breast Cancer
NCT01910870

Terminated

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes

Metastatic Breast Cancer
NCT01887288

Terminated

Capecitabine With Digoxin for Metastatic Breast Cancer

Metastatic Breast Cancer
NCT03086785

Unknown

Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast Cancer

Breast Cancer Metastatic
NCT01779479

Completed

Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE)

Primary Breast Cancer
NCT02555696

Completed

Abraxane in Treatment of Metastatic Breast Cancer

Metastatic Breast Cancer
NCT01027208

Completed

A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline

Metastatic Breast Cancer
NCT01091584

Completed

Nurse Intervention Project (VIP)

Breast Cancer Patients
NCT02333890

Unknown

A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer (CUBiC)

Breast Cancer | Invasive Breast Cancer
NCT01855503

Completed

Breast Cancer Molecular Analysis Protocol (MAP-IT)

Metastatic Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations